Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2012
04/19/2012WO2011091205A3 Intracameral sustained release therapeutic agent implants
04/19/2012WO2011073234A3 Dry growth hormone composition transiently linked to a polymer carrier
04/19/2012WO2011031855A3 Implantable device for controlled drug delivery
04/19/2012WO2011031621A8 High strength seamless alginate capsules
04/19/2012US20120095558 Synthetic bone grafts constructed from carbon foam materials
04/19/2012US20120095418 Self-Supporting Films For Delivery Of Therapeutic Agents
04/19/2012US20120095390 Generation of Therapeutic Microfoam
04/19/2012US20120095388 Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues
04/19/2012US20120095386 Composition and device structure for iontophoresis
04/19/2012US20120095235 Thioflavin derivates for use in the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
04/19/2012US20120095090 Novel composition and method for stabilizing the same
04/19/2012US20120094960 Dosage forms of risedronate
04/19/2012US20120094008 Nano- and Micro- Encapsulation of Biomaterials Into Particles and Capsules by Varying Precipitation Conditions
04/19/2012US20120093940 Medical food or nutritional supplement for managing blood glucose levels and method of manufacturing same
04/19/2012US20120093939 Oral formulations
04/19/2012US20120093938 Orally disintegrating tablets comprising diphenhydramine
04/19/2012US20120093937 Encapsulated liver cell composition
04/19/2012US20120093936 Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
04/19/2012US20120093935 Particles having a luminescent inorganic shell, method for coating particles and use thereof
04/19/2012US20120093934 Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres
04/19/2012US20120093933 Denatured lactoglobulin and polyphenol coassemblies
04/19/2012US20120093932 Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof
04/19/2012US20120093931 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
04/19/2012US20120093930 Article and method for focused delivery of therapeutic and/or diagnostic materials
04/19/2012US20120093929 Opioid Composition for Treating Skin Lesions
04/19/2012US20120093928 Oral metaxalone compositions
04/19/2012US20120093927 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
04/19/2012US20120093926 Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
04/19/2012US20120093925 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
04/19/2012US20120093924 Methods of treating hypertriglyceridemia
04/19/2012US20120093923 Apparatus And Methods For Delivering A Plurality Of Medicaments For Management Of Co-Morbid Diseases, Illnesses, Or Conditions
04/19/2012US20120093922 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
04/19/2012US20120093921 Immunogenic compositions having low sodium chloride concentration
04/19/2012US20120093920 Method of treatment for bladder dysfunction
04/19/2012US20120093919 E2f as a target of hormone refractory prostate cancer
04/19/2012US20120093918 Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
04/19/2012US20120093917 Metnase and intnase inhibitors and their use in treating cancer
04/19/2012US20120093916 Devices, Systems and Methods for Improving Memory and/or Cognitive Function Through Brain Delivery of SIRNA
04/19/2012US20120093915 Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids
04/19/2012US20120093914 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone particles as scaffolds for tissue regeneration
04/19/2012US20120093913 Inhibition of SYK kinase expression
04/19/2012US20120093912 Biomimetic Nanofiber Web And Method And Device To Manufacture The Same
04/19/2012US20120093911 Platinum-catalyzed intravaginal rings
04/19/2012US20120093910 Non-hormonal vaginal contraceptive
04/19/2012US20120093909 Ceramic Coatings and Applications Thereof
04/19/2012US20120093904 Composition comprising an anionic polymeric material and the salt of a saturated monocarboxylic acid having 6 to 22 carbon atoms
04/19/2012US20120093903 Powdery or granulated composition comprising a copolymer, a salt of a fatty monocarboxylic acid and a fatty monocarboxylic acid and/or a fatty alcohol
04/19/2012US20120093901 Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of a cosmetic or pharmaceutical agent other than water
04/19/2012US20120093898 Metal Ion Nanoclusters
04/19/2012US20120093895 Bone-repair composition
04/19/2012US20120093894 Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
04/19/2012US20120093893 Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
04/19/2012US20120093892 Minocycline oral dosage forms for the treatment of acne
04/19/2012US20120093891 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120093890 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
04/19/2012US20120093889 Layered pharmaceutical formulations
04/19/2012US20120093888 micro-emulsions for the treatment of rheumatic disorders
04/19/2012US20120093887 Amorphous varenicline tartrate co-precipitates
04/19/2012US20120093886 Pharmaceutical compositions and related methods of delivery
04/19/2012US20120093885 Therapeutic vesicles
04/19/2012US20120093884 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012US20120093883 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
04/19/2012US20120093882 Stable pharmaceutical compositions of diclofenac
04/19/2012US20120093881 Disruptive polymer micelle composition
04/19/2012US20120093880 Method and kit for topical elimination of psoriatic lesions with a caustic applicator
04/19/2012US20120093879 Cardiac stem cells and uses of same in cardiac repair
04/19/2012US20120093878 Pharmaceutical compositions containing a biguanide and a thiazolidinedione
04/19/2012US20120093877 Collagen scaffold for cell growth and a method for producing same
04/19/2012US20120093876 Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions
04/19/2012US20120093740 Peptide fragments for inducing synthesis of extracellular matrix proteins
04/19/2012US20120093739 Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore
04/19/2012US20120093738 Taste-masked oral formulations of influenza antivirals
04/19/2012US20120093731 Gas-filled microvesicles with targeting ligand or therapeutic agent
04/19/2012US20120093722 Synthetic diblock copolypeptide hydrogels for use in the central nervous system
04/19/2012US20120093718 Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
04/19/2012US20120093717 Microsphere/nanofiber composites for delivery of drugs, growth factors, and other agents
04/19/2012US20120091605 Chewable Soft Capsule
04/19/2012US20120090630 Flameless electronic atomizing cigarette
04/19/2012US20120090604 Synthesis of small particles
04/19/2012DE102010048883A1 Use of buprenorphine for abuse protection in pharmaceutical compositions containing a opioid full-agonist
04/19/2012DE102010048408A1 Laminat mit verbessertem Wasserretentionsverhalten Laminate with improved water retention behavior
04/19/2012CA2850468A1 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
04/19/2012CA2814696A1 Pharmaceutical formulation for histone deacetylase inhibitors
04/19/2012CA2814676A1 Use of monoamine oxidase inhibitors to improve epithelial biology
04/19/2012CA2814495A1 Clevidipine emulsion formulations containing antimicrobial agents
04/19/2012CA2814445A1 Pharmaceutical composition
04/19/2012CA2814097A1 Composition for treating cancer by the controlled release of an active substance
04/19/2012CA2814082A1 Non-starch based soft chewables
04/19/2012CA2814054A1 Formulation suitable for stabilizing proteins, which is free of mammalian excipients
04/19/2012CA2813788A1 Suction device
04/19/2012CA2813781A1 Pharmaceutical compositions containing a dgat1 inhibitor
04/19/2012CA2813750A1 Method for treating cystic fibrosis with inhaled denufosol
04/19/2012CA2812417A1 Cationic dry powders
04/19/2012CA2807621A1 Phosphate binder formulation for simple dosing
04/19/2012CA2755150A1 Methods of forming self-supporting films for delivery of therapeutic agents
04/19/2012CA2755081A1 Self-supporting films for delivery of therapeutic agents
04/19/2012CA2754991A1 Methods of forming self-supporting films for delivery of therapeutic agents
04/18/2012EP2441779A1 Process for the preparation of sevelamer hydrochloride and formulation thereof
04/18/2012EP2441477A1 Wound-covering material
04/18/2012EP2441458A1 A vascular protecting agent having salt-absorption inhibitory activity
1 ... 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 ... 2991